IP Library Granted Patent US 9,931,423
Granted Patent B2
US 9,931,423 · App. 14/240,712 · Granted Apr 3, 2018

Methods of sterilizing fetal support tissues

Inventors: Scheffer Tseng (Pinecrest, FL); Ek Kia Tan (Miami, FL)
Assignee: TISSUETECH, INC.
A61L2/0035A01N1/021A61K35/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,423
App. No.
14/240,712
Granted
Apr 3, 2018
Kind
B2
Abstract

Disclosed herein, are methods of preparing sterilized amniotic tissues. Further disclosed herein, are methods of using the sterilized amniotic tissues.

Claims (9)

1. A sterilized fetal support tissue product, comprising: (i) a fetal support tissue that is not dry, and (ii) an isotonic solution; wherein:

a) the fetal support tissue product is sterilized by exposing the fetal support tissue in combination with the isotonic solution to γ-irradiation at a temperature of less than or equal to 0° C., and at a dosage sufficient to sterilize the fetal support tissue product;

b) anti-inflammatory activity of HC-HA/PTX3 of the fetal support tissue is substantially maintained in the sterilized fetal support tissue product, and is stable at room temperature for at least 1 month; and

c) the sterilized fetal support tissue product comprises cells, substantially all of which are dead.

2. The sterilized fetal support tissue product of claim 1 , wherein the sterilized fetal support tissue product has a Sterility Assurance Level (SAL) of 10 −6 .

3. The sterilized fetal support tissue product of claim 1 , wherein structural integrity of the fetal support tissue is maintained.

4. The sterilized fetal support tissue product of claim 1 , wherein the sterilized fetal support tissue is stable at room temperature for at least 6 months.

5. The sterilized fetal support tissue product of claim 1 , wherein the fetal support tissue is from placental amniotic membrane, umbilical cord amniotic membrane, chorion, amnion-chorion, placenta, umbilical cord, or a any combination thereof.

6. The sterilized fetal support tissue product of claim 1 , wherein the fetal support tissue is a tissue graft.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FINANCIAL TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0165 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FUNDING IV TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0200 →
SECURITY INTEREST Recorded Jun 7, 2024
From: BIOTISSUE HOLDINGS INC.; BIOTISSUE OCULAR INC.; BIOTISSUE SURGICAL INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 067666/0235 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - TERM LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060116/0413 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - REVOLVING LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 060116/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: TSENG, SCHEFFER; TAN, EK KIA
To: TISSUETECH, INC.
Reel/Frame 032864/0830 →
Continuity (2)
Provisional Application 61528059 · Aug 26, 2011
Related Publication 20140342014A1 · Nov 20, 2014